early-stage epigenetic modification somatic cell reprogramming parp1 tet2 
somatic cells can reprogrammed induced pluripotent stem cells ipscs using pluripotency factors oct4 sox2 klf4 c-myc together referred oskm ipsc reprogramming erases somatic epigenetic signatures-as typified dna methylation histone modification silent pluripotency loci-and establishes alternative epigenetic marks embryonic stem cells escs describe early essential stage somatic cell reprogramming preceding induction transcription endogenous pluripotency loci nanog esrrb day transduction oskm two epigenetic modification factors necessary ipsc generation namely polyadp-ribose polymerase parp1 ten-eleven translocation tet2 recruited nanog esrrb loci epigenetic modification factors seem complementary roles establishment early epigenetic marks somatic cell reprogramming: parp1 functions regulation methylcytosine 5mc modification whereas tet2 essential early generation hydroxymethylcytosine 5hmc oxidation 5mc refs although 5hmc proposed serve primarily intermediate 5mc demethylation cytosine certain contexts- data also studies tet2-mutant human tumour cells argue favour role 5hmc epigenetic mark distinct 5mc consistent parp1 tet2 needed early establishment histone modifications typify activated chromatin state pluripotency loci whereas parp1 induction promotes accessibility oct4 reprogramming factor findings suggest parp1 tet2 contribute epigenetic program directs subsequent transcriptional induction pluripotency loci somatic cell reprogramming 
